>
Organization
MedImmune LLC
Topic
All Topics
People
Find news about people
Alumni
Find news on alumni of any org
Industries
Find news on a particular market
Your Contacts
Find news on your contacts
Sign up for free daily alerts on this feed:
By pressing Sign Up, you agree to our Terms of Use, Privacy Policy, and the LexisNexis Terms & Conditions

Follow

Change Feed

News on MedImmune LLC

... may also enhance the cytotoxic potential of other therapeutic antibodies. AstraZeneca and MedImmune, AstraZeneca's global biologics research and development arm, obtained full oncology rights to ...
... these Phase 2 studies are expected in 2019.MEDI0457 (formerly INO-3112, licensed to MedImmune)The October issue of Clinical Cancer Research detailed results of a patient with ...
... speaker is Dr. JoAnn Suzich, vice president of research at Gaithersburg, Md.-based MedImmune, the global biologics research and development unit of AstraZeneca. Dr. Suzich will ...
... with 50 Sales Representatives Recruited and in Training Clinical Collaboration Agreement with AstraZeneca/MedImmune Expanded to Include Non-Small Cell Lung Cancer MORRIS PLAINS, N.J., Nov. 07, ...
... announced that new data from ongoing clinical trials evaluating monalizumab, partnered with AstraZeneca/MedImmune, and first-in-class antibody, IPH4102, will be presented at the SITC[1] 2018 Annual ...
... with some medical conditions whoshould not receive the nasal spray flu vaccine. MedImmune's FluMist was the first influenza vaccine delivered as a nasal mist to ...
... to Verastem, she was the Vice President in Immuno-Oncology Innovative Medicines at MedImmune, a subsidiary of AstraZeneca. In this executive role, she led the product ...
... AstraZeneca and MedImmune, its global biologics research and development arm, will present 54 abstracts, including ...
... that will present immuno-oncology (IO) testing experiences at the Forum. Speakers from MedImmune, Boehringer-Ingelheim, and Covance/LabCorp will also share their experiences and best practices. The ...
... AstraZeneca and MedImmune, its global biologics research and development arm, today announced that the European ...
Subscribe now for full coverage on MedImmune LLC
Start My Free Trial